1. Home
  2. AU vs RGEN Comparison

AU vs RGEN Comparison

Compare AU & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AngloGold Ashanti PLC

AU

AngloGold Ashanti PLC

HOLD

Current Price

$84.57

Market Cap

34.6B

ML Signal

HOLD

Logo Repligen Corporation

RGEN

Repligen Corporation

HOLD

Current Price

$160.33

Market Cap

8.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AU
RGEN
Founded
1944
1981
Country
United States
United States
Employees
N/A
N/A
Industry
Precious Metals
Medical/Dental Instruments
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
34.6B
8.2B
IPO Year
1972
N/A

Fundamental Metrics

Financial Performance
Metric
AU
RGEN
Price
$84.57
$160.33
Analyst Decision
Buy
Buy
Analyst Count
6
10
Target Price
$76.33
$170.90
AVG Volume (30 Days)
2.9M
724.0K
Earning Date
11-11-2025
10-28-2025
Dividend Yield
2.36%
N/A
EPS Growth
237.48
N/A
EPS
4.53
0.03
Revenue
$8,575,000,000.00
$707,890,000.00
Revenue This Year
$71.66
$17.84
Revenue Next Year
$13.65
$12.57
P/E Ratio
$18.32
$6,185.26
Revenue Growth
61.82
11.74
52 Week Low
$22.45
$102.97
52 Week High
$89.19
$182.52

Technical Indicators

Market Signals
Indicator
AU
RGEN
Relative Strength Index (RSI) 57.24 51.46
Support Level $78.07 $156.31
Resistance Level $86.78 $165.02
Average True Range (ATR) 3.13 4.73
MACD -0.42 -1.26
Stochastic Oscillator 58.14 24.04

Price Performance

Historical Comparison
AU
RGEN

About AU AngloGold Ashanti PLC

Anglogold Ashanti PLC is one of the gold miners. The company also produces silver and sulphuric acid as by-products. Its operating divisions are Africa, Australia, and the Americas. The firm generates a majority of its revenue from the Africa region which includes its operations of the Kibali, Iduapriem, Obuasi, Siguiri, and Geita mines.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: